Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures

Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures

Glioblastomas (GBM) are the most common, primary brain tumors in adults. Despite advances in neurosurgery and radio- and chemotherapy, the median survival of GBM patients is 15 months. Recent large-scale genomic, transcriptomic and epigenetic analyses have shown the cellular and molecular heterogene...

Full description

Bibliographic Details
Main Authors: Iwona A. Ciechomska, Kamil Wojnicki, Bartosz Wojtas, Paulina Szadkowska, Katarzyna Poleszak, Beata Kaza, Kinga Jaskula, Wiktoria Dawidczyk, Ryszard Czepko, Mariusz Banach, Bartosz Czapski, Pawel Nauman, Katarzyna Kotulska, Wieslawa Grajkowska, Marcin Roszkowski, Tomasz Czernicki, Andrzej Marchel, Bozena Kaminska
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
glioblastoma
cancer stem cells
EMT
MGMT
temozolomide
doxorubicin
Online Access:https://www.mdpi.com/2072-6694/15/5/1562

Internet

https://www.mdpi.com/2072-6694/15/5/1562

Similar Items